Alnylam Pharmaceuticals
ALNY
#564
Rank
โ‚น4.019 T
Marketcap
โ‚น30,304
Share price
0.51%
Change (1 day)
40.42%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Net assets

Net assets on the balance sheet as of December 2025 : โ‚น71.83 Billion

According to Alnylam Pharmaceuticals 's latest financial reports the company has โ‚น71.83 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Alnylam Pharmaceuticals - Net assets on balance sheet (from 2003 to 2025)

Net assets by year

Year Net assets Change
2025-12-31$โ‚น70.84 B1130.94%
2024-12-31$โ‚น5.75 B-131.33%
2023-12-31$-โ‚น18.37 Billion40.29%
2022-12-31$-โ‚น13.1 Billion-129.91%
2021-12-31$โ‚น43.78 B-41.09%
2020-12-31$โ‚น74.32 B-27.56%
2019-12-31$โ‚น102.59 B12.7%
2018-12-31$โ‚น91.03 B-19.29%
2017-12-31$โ‚น112.78 B80.36%
2016-12-31$โ‚น62.53 B-25.6%
2015-12-31$โ‚น84.04 B41.64%
2014-12-31$โ‚น59.33 B255.28%
2013-12-31$โ‚น16.70 B127.55%
2012-12-31$โ‚น7.33 B17.59%
2011-12-31$โ‚น6.24 B-11.97%
2010-12-31$โ‚น7.09 B-14.13%
2009-12-31$โ‚น8.25 B-15%
2008-12-31$โ‚น9.71 B24.29%
2007-12-31$โ‚น7.81 B-12.27%
2006-12-31$โ‚น8.90 B220.5%
2005-12-31$โ‚น2.78 B39.12%
2004-12-31$โ‚น1.99 B-264.34%
2003-12-31$-โ‚น1.22 Billion445.78%
2002-12-31$-โ‚น0.23 Billion

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Novartis
NVS
โ‚น4.237 T 5,798.43%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚น7.855 T 10,835.10%๐Ÿ‡ซ๐Ÿ‡ท France
Regeneron Pharmaceuticals
REGN
โ‚น2.845 T 3,860.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น120.16 B 67.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
โ‚น6.28 B-91.25%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
โ‚น118.83 B 65.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น720.37 B 902.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Arrowhead Pharmaceuticals
ARWR
โ‚น51.22 B-28.70%๐Ÿ‡บ๐Ÿ‡ธ USA